Sucampo Reports Strong Results for First Quarter of 2016
04 mai 2016 06h30 HE
|
Sucampo Pharmaceuticals Inc
Results Driven by 60% Growth in Revenue Company Reiterates 2016 Guidance Company to Host Conference Call Today at 8:30 a.m. EDT ROCKVILLE, Md., May 04, 2016 (GLOBE NEWSWIRE) -- Sucampo...
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Bank of America Merrill Lynch 2016 Healthcare Conference
03 mai 2016 06h45 HE
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., May 03, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo Announces First Quarter 2016 Earnings Call
20 avr. 2016 06h45 HE
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., April 20, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its first quarter...
Sucampo Reports Top-Line Data from Phase 2a Study of Cobiprostone in Patients with PPI-Refractory Non-Erosive Reflux Disease (NERD) and Symptomatic Gastroesophageal Reflux Disease (sGERD)
19 avr. 2016 07h00 HE
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., April 19, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced top-line data from a Phase 2a study of...
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 28th Annual ROTH Conference
09 mars 2016 06h45 HE
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., March 09, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo Reports Continued Strong Performance for Fourth Quarter and Full Year 2015
08 mars 2016 06h30 HE
|
Sucampo Pharmaceuticals Inc
Results Driven by Continued AMITIZA Growth and R-TECH UENO Acquisition Company Reiterates 2016 Guidance Company to Host Conference Call Today at 8:30 a.m. EST ROCKVILLE, Md., March 08, 2016 ...
Sucampo Announces Fourth Quarter and Full Year 2015 Earnings Call
23 févr. 2016 06h45 HE
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Feb. 23, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its fourth quarter...
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2016 Leerink Global Healthcare Conference
04 févr. 2016 06h30 HE
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will participate in a fireside...
Sucampo Enters Into Exclusive Option and Collaboration Agreement With Cancer Prevention Pharmaceuticals for Development of Late-Stage CPP-1X/Sulindac Combination for Familial Adenomatous Polyposis
11 janv. 2016 06h45 HE
|
Sucampo Pharmaceuticals Inc
Addresses Significant Patient Need Aligned With GI Expertise, Strategic Focus Phase 3 Study Expected to be Complete in 2018 ROCKVILLE, Md., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Sucampo...
Sucampo Provides Update to 2015 and Confirms 2016 Financial Guidance Post Closing of R-Tech Ueno Acquisition
07 janv. 2016 07h00 HE
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today provided additional detail regarding its...